Ambu ASAMBBY 84 PB Ratio is 2.65 as of Jun. 26, 2026, which is 78% below its 10-year median of 12.18. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.37 (Significantly Undervalued). Among 788 Medical Devices & Instruments companies, Ambu AS ranks worse than 59.39% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Ambu AS's share price is $9.43. Ambu AS's Book Value per Share for the quarter that ended in Mar. 2026 was $3.56. Hence, Ambu AS's PB Ratio of today is 2.65.
Good Sign:
Ambu AS stock PB Ratio (=2.56) is close to 10-year low of 2.56.
The historical rank and industry rank for Ambu AS's PB Ratio or its related term are showing as below:
AMBBY'
s PB Ratio Range Over the Past 10 Years
Min: 2.56 Med: 12.18 Max: 35.71
Current: 2.82
During the past 13 years, Ambu AS's highest PB Ratio was 35.71. The lowest was 2.56. And the median was 12.18.
AMBBY's PB Ratio is ranked worse than 59.39% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs AMBBY: 2.82
During the past 12 months, Ambu AS's average Book Value Per Share Growth Rate was 3.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 10.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 16.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 20.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Ambu AS was 28.40% per year. The lowest was -0.40% per year. And the median was 10.55% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Ambu AS PB Ratio Related Terms
Ambu AS PB Ratio Historical Data
* Premium members only.
The historical data trend for Ambu AS's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ambu AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's PB Ratio distribution charts can be found below:
* The bar in red indicates where Ambu AS's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Ambu AS's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Ambu AS (AMBBY) has a PB Ratio of 2.65 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ambu AS and its competitors. This is 78% below median its historical median of 12.18. Over the past decade, Ambu AS's PB Ratio has ranged from 2.56 to 35.71. According to the industry distribution chart, Ambu AS ranks #468 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 59.4%.
Is Ambu AS's PB Ratio too high?
Ambu AS's current PB Ratio of 2.65 is 78% below median its 10-year median of 12.18. Over the past 10 years, this metric has ranged from a low of 2.56 to a high of 35.71. The Medical Devices & Instruments industry median PB Ratio is 2.02. Ambu AS's value of 2.65 is 31.2% above this industry median. Based on the distribution chart, Ambu AS ranks #468 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #468 out of 788 companies for PB Ratio. This places Ambu AS in the lower half of its industry. The industry median PB Ratio is 2.02. Ambu AS's value of 2.65 is 31.2% above this benchmark. Historically, Ambu AS's own PB Ratio has ranged from 2.56 to 35.71 over the past decade. While the company's 10-year median is 12.18 vs. the industry median of 2.02, Ambu AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current PB Ratio of 2.65 is 31.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current PB Ratio is 2.65, which is 78% below median its own 10-year median of 12.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.37, compared to a current price of $9.43 — trading 51.3% below its estimated fair value. The current PB Ratio is 2.65, which is 78% below median its 10-year median of 12.18 and 31.2% above the Medical Devices & Instruments industry median of 2.02. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Ambu AS (AMBBY), the current PB Ratio is 2.65 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (AMBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of $9.43 is trading 51.3% below its estimated GF Value™ of $19.37.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for AMBBY:
PB Ratio: 2.65 (78% below median its 10-year median of 12.18)
GF Value™: $19.37 vs. price of $9.43 (51.3% below fair value)
Industry Position: 31.2% above the Medical Devices & Instruments median (#468 of 788)
No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score
Get the complete analysis for AMBBY
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMBBY has been successfully added to your 
